In vivo and in vitro Effects of Substance P on the Release of β-Endorphin-Like Immunoreactivity

Authors:
  • MMMitsuhiro Matsumura
    Mitsuhiro Matsumura
  • AYAkira Yamanoi
    Akira Yamanoi
  • SYShigeru Yamamoto
    Shigeru Yamamoto
  • SSShiro Saito
    Shiro Saito

Abstract
The effect of substance P (SP) on the release of β-endorphin-like immunoreactivity (β-EpLI) in rats was studied in vivo and in vitro. Intravenous injection of 5 μg/100 g BW of SP resulted in significant increase in the plasma β-EpLI level after 15 and 30 min. SP at concentrations of 10–9 to 10–6 Malso caused dose-dependent stimulation of β-EpLI release from dispersed cells of rat anterior pituitary. On gel-chromatography, the β-EpLI released by incubation of the cells with 10 7M SP separated into two components, eluted in the same positions as human β-lipotropin and human β-Ep, respectively. Release of β-EpLI from the cells was increased by the addition of K+ at high concentration (53 mM) in a Ca++-dependent manner. Addition of 10–3M verapamil to the incubation medium inhibited SP-induced β-EpLI release from the cells. Ouabain (10–5M) had a stimulatory effect on β-EpLI release which was not additive with that of SP. These results indicate that SP acts directly on the anterior pituitary cells to stimulate β-EpLI release and that calcium ion is involved in the mechanism of this effect.

This publication has 14 references indexed in Scilit: